Theratechnologies Inc (THTX)
1.21
-0.01
(-0.82%)
USD |
NASDAQ |
Nov 14, 16:00
1.21
0.00 (0.00%)
After-Hours: 20:00
Theratechnologies EPS Diluted (Quarterly): 0.06 for Aug. 31, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2024 | 0.06 |
| May 31, 2024 | 0.02 |
| February 29, 2024 | -0.10 |
| November 30, 2023 | -0.03 |
| August 31, 2023 | -0.03 |
| May 31, 2023 | -0.41 |
| February 28, 2023 | -0.4315 |
| November 30, 2022 | -0.33 |
| August 31, 2022 | -0.32 |
| May 31, 2022 | -0.96 |
| February 28, 2022 | -0.36 |
| November 30, 2021 | -0.41 |
| August 31, 2021 | -0.40 |
| May 31, 2021 | -0.28 |
| February 28, 2021 | -0.28 |
| November 30, 2020 | -0.28 |
| August 31, 2020 | -0.36 |
| May 31, 2020 | -0.32 |
| February 29, 2020 | -0.24 |
| November 30, 2019 | -0.32 |
| August 31, 2019 | -0.08 |
| May 31, 2019 | -0.16 |
| February 28, 2019 | -0.08 |
| November 30, 2018 | -0.04 |
| August 31, 2018 | 0.0144 |
| Date | Value |
|---|---|
| May 31, 2018 | -0.12 |
| February 28, 2018 | -0.12 |
| November 30, 2017 | -0.1433 |
| August 31, 2017 | -0.1268 |
| May 31, 2017 | -0.3563 |
| February 28, 2017 | -0.091 |
| November 30, 2016 | 0.0188 |
| August 31, 2016 | 0.0306 |
| May 31, 2016 | -0.0307 |
| February 29, 2016 | -0.0069 |
| November 30, 2015 | -0.0006 |
| August 31, 2015 | 0.0604 |
| May 31, 2015 | 0.0322 |
| February 28, 2015 | -0.032 |
| November 30, 2014 | -0.189 |
| August 31, 2014 | -0.2575 |
| May 31, 2014 | 0.0737 |
| February 28, 2014 | -0.2157 |
| November 30, 2013 | -0.1878 |
| August 31, 2013 | -0.1138 |
| May 31, 2013 | -0.0776 |
| February 28, 2013 | 0.1172 |
| November 30, 2012 | -0.2817 |
| August 31, 2012 | -0.0403 |
| May 31, 2012 | -0.0776 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.96
Minimum
May 2022
0.06
Maximum
Aug 2024
-0.2891
Average
-0.32
Median
Nov 2019
EPS Diluted (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 0.10 |
| Edesa Biotech Inc | -0.52 |
| Lexaria Bioscience Corp | -0.13 |
| InMed Pharmaceuticals Inc | -0.19 |
| Xenon Pharmaceuticals Inc | -0.75 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.091M |
| Revenue (Quarterly) | 22.60M |
| Total Expenses (Quarterly) | 16.39M |
| Enterprise Value | 74.38M |
| Gross Profit Margin (Quarterly) | 80.00% |
| Profit Margin (Quarterly) | 13.68% |
| Earnings Yield | -4.13% |
| Operating Earnings Yield | 18.14% |
| Normalized Earnings Yield | -1.952 |